Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Recruiting 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 11Gastrointestinal 6Genitourinary 4Thoracic 3Tumor-Agnostic 2Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Gynecologic 1

Conditions

Lung Neoplasms 3Stomach Neoplasms 1Psychological Well-Being 1Motor Activity 1Infections 1Esophageal Neoplasms 1

Interventions

Carboplatin 1145Cisplatin 874Pemetrexed 832pembrolizumab 604Paclitaxel 597Docetaxel 535Gemcitabine 424Radiotherapy 374Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 294durvalumab 254Drug Therapy 233osimertinib 217atezolizumab 207Radiosurgery 188Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 123Magnetic Resonance Spectroscopy 120Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Fish Oils × Thoracic × Clear all
NCT04871412 2026-01-30

POISE

Ottawa Hospital Research Institute

Phase 3 Recruiting
20 enrolled
GastrointestinalThoracic

Psychological Well-Being, Esophageal Neoplasms, Lung Neoplasms, Motor Activity, Stomach Neoplasms

NCT06531460 2024-08-01

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

National Institute of Respiratory Diseases, Mexico

Phase NA Recruiting
310 enrolled
Thoracic

Infections, Lung Neoplasms

NCT04965129 2024-05-17

Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet

Universidade Federal do Rio de Janeiro

Phase NA Recruiting
50 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡